David H. Clarke, Former CEO and Director at INNOVATE BIOPHARMACEUTICALS, INC. (INNT), bought 1,813,513 shares at $4.50 ($807K) on 2016-07-13, disclosed to the SEC on 2018-03-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.50 | 15,000 | $68K | 8.4% |
| 2 | $0.00 | 175,000 | $0 | 0.0% |
| 3 | $1.50 | 70,000 | $105K | 13.0% |
| 4 | $0.58 | 172,414 | $100K | 12.4% |
| 5 | $0.58 | 172,414 | $100K | 12.4% |
| 6 | $0.00 | 33,621 |
| $0 |
| 0.0% |
| 7 | $0.00 | 100,000 | $0 | 0.0% |
| 8 | $0.45 | 366,159 | $165K | 20.4% |
| 9 | $0.45 | 366,159 | $165K | 20.4% |
| 10 | $0.00 | 17,746 | $0 | 0.0% |
| 11 | $0.00 | 25,000 | $0 | 0.0% |
| 12 | $0.35 | 300,000 | $105K | 13.0% |
| Total | $0.45 avg | 1,813,513 | $807K | 100% |